LT2838539T - Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymui - Google Patents
Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymuiInfo
- Publication number
- LT2838539T LT2838539T LTEP13714917.5T LT13714917T LT2838539T LT 2838539 T LT2838539 T LT 2838539T LT 13714917 T LT13714917 T LT 13714917T LT 2838539 T LT2838539 T LT 2838539T
- Authority
- LT
- Lithuania
- Prior art keywords
- treatment
- neurological disorders
- estrogenic derivatives
- estrogenic
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12164741.6A EP2653163A1 (en) | 2012-04-19 | 2012-04-19 | Estrogenic components for use in the treatment of neurological disorders |
PCT/EP2013/057279 WO2013156329A1 (en) | 2012-04-19 | 2013-04-08 | Estrogenic components for use in the treatment of neurological disorders. |
Publications (1)
Publication Number | Publication Date |
---|---|
LT2838539T true LT2838539T (lt) | 2017-11-27 |
Family
ID=48050711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP13714917.5T LT2838539T (lt) | 2012-04-19 | 2013-04-08 | Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymui |
Country Status (19)
Country | Link |
---|---|
US (1) | US9238035B2 (lt) |
EP (2) | EP2653163A1 (lt) |
JP (1) | JP6139662B2 (lt) |
CN (1) | CN104379148B (lt) |
AU (1) | AU2013248481B2 (lt) |
CA (1) | CA2869902C (lt) |
CY (1) | CY1119603T1 (lt) |
DK (1) | DK2838539T3 (lt) |
ES (1) | ES2647111T3 (lt) |
HR (1) | HRP20171627T1 (lt) |
HU (1) | HUE034902T2 (lt) |
LT (1) | LT2838539T (lt) |
NO (1) | NO2838539T3 (lt) |
PL (1) | PL2838539T3 (lt) |
PT (1) | PT2838539T (lt) |
RS (1) | RS56595B1 (lt) |
RU (1) | RU2627846C2 (lt) |
SI (1) | SI2838539T1 (lt) |
WO (1) | WO2013156329A1 (lt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2714712T (pt) | 2011-06-01 | 2016-11-08 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
WO2012164096A1 (en) | 2011-06-01 | 2012-12-06 | Estetra S.A. | Process for the production of estetrol intermediates |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
US11638745B2 (en) * | 2015-05-20 | 2023-05-02 | University of Pittsburgh—Of the Commonwealth Cvctom of Hierher Education | Method to improve neurologic outcomes in temperature managed patients |
MX2017016276A (es) * | 2015-06-18 | 2018-06-19 | Mithra Pharmaceuticals S A | Unidad de dosificacion orodispersable que contiene un componente estetrol. |
TN2017000497A1 (en) | 2015-06-18 | 2019-04-12 | Mithra Pharmaceuticals S A | Orodispersible dosage unit containing an estetrol component |
MA44205B1 (fr) | 2015-06-18 | 2021-04-30 | Estetra Sprl | Comprimé orodispersible comprenant estetrol |
LT3310346T (lt) * | 2015-06-18 | 2021-06-10 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
CN107260712A (zh) * | 2017-06-22 | 2017-10-20 | 中国人民解放军第三军医大学 | 奥培米芬在制备促进髓鞘形成和再生的药物中的应用 |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
HU231240B1 (hu) | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
CN113243332B (zh) * | 2020-02-07 | 2023-07-28 | 上海市东方医院(同济大学附属东方医院) | 一种广泛脑区神经元树突发育障碍动物模型的制备与应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2378898A (en) * | 2001-08-14 | 2003-02-26 | Hunter Fleming Ltd | Prophylactic and therapeutic use of hydroxysteroids |
AU2003274943A1 (en) | 2002-06-11 | 2003-12-22 | Pantarhei Bioscience B.V. | Use of estetrol and analogues for treating or preventing cardiovascular pathologies, in particular atherosclerosis |
CN1691947B (zh) * | 2002-06-11 | 2011-11-23 | 潘塔希生物科学股份有限公司 | 雌激素成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述雌激素成分的药物组合物 |
CA2623839C (en) * | 2005-09-26 | 2013-12-17 | The Regents Of The University Of California | Estriol therapy for autoimmune and neurodegenerataive diseases and disorders |
EP1971344B1 (en) * | 2006-01-09 | 2010-09-22 | Pantarhei Bioscience B.V. | A method of treating an acute vascular disorder |
CN102014924B (zh) * | 2007-06-21 | 2012-07-18 | 潘塔希生物科学股份有限公司 | 用雌激素治疗胎粪吸入综合征 |
CA2704921C (en) * | 2007-11-06 | 2015-11-24 | Ellis L. Kline | Compositions and methods for treating parkinson's disease and related disorders |
CN101884638B (zh) * | 2010-07-09 | 2011-11-09 | 中山大学 | 5α-雄甾(烷)-3β,5,6β-三醇在制备神经元保护药物中的应用 |
-
2012
- 2012-04-19 EP EP12164741.6A patent/EP2653163A1/en not_active Withdrawn
-
2013
- 2013-04-08 PL PL13714917T patent/PL2838539T3/pl unknown
- 2013-04-08 JP JP2015506173A patent/JP6139662B2/ja active Active
- 2013-04-08 SI SI201330825T patent/SI2838539T1/sl unknown
- 2013-04-08 ES ES13714917.5T patent/ES2647111T3/es active Active
- 2013-04-08 US US14/395,465 patent/US9238035B2/en active Active
- 2013-04-08 LT LTEP13714917.5T patent/LT2838539T/lt unknown
- 2013-04-08 WO PCT/EP2013/057279 patent/WO2013156329A1/en active Application Filing
- 2013-04-08 NO NO13714917A patent/NO2838539T3/no unknown
- 2013-04-08 CA CA2869902A patent/CA2869902C/en active Active
- 2013-04-08 DK DK13714917.5T patent/DK2838539T3/da active
- 2013-04-08 EP EP13714917.5A patent/EP2838539B1/en active Active
- 2013-04-08 RS RS20171122A patent/RS56595B1/sr unknown
- 2013-04-08 HU HUE13714917A patent/HUE034902T2/hu unknown
- 2013-04-08 PT PT137149175T patent/PT2838539T/pt unknown
- 2013-04-08 CN CN201380020555.6A patent/CN104379148B/zh active Active
- 2013-04-08 RU RU2014145800A patent/RU2627846C2/ru active
- 2013-04-08 AU AU2013248481A patent/AU2013248481B2/en active Active
-
2017
- 2017-10-25 HR HRP20171627TT patent/HRP20171627T1/hr unknown
- 2017-11-14 CY CY20171101193T patent/CY1119603T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
RU2014145800A (ru) | 2016-06-10 |
CN104379148B (zh) | 2017-08-25 |
PT2838539T (pt) | 2017-11-15 |
CN104379148A (zh) | 2015-02-25 |
EP2653163A1 (en) | 2013-10-23 |
ES2647111T3 (es) | 2017-12-19 |
SI2838539T1 (sl) | 2017-12-29 |
HRP20171627T1 (hr) | 2017-12-01 |
US9238035B2 (en) | 2016-01-19 |
US20150133419A1 (en) | 2015-05-14 |
DK2838539T3 (da) | 2017-11-27 |
JP6139662B2 (ja) | 2017-05-31 |
EP2838539A1 (en) | 2015-02-25 |
CY1119603T1 (el) | 2018-04-04 |
EP2838539B1 (en) | 2017-08-16 |
AU2013248481A1 (en) | 2014-10-30 |
RS56595B1 (sr) | 2018-02-28 |
NO2838539T3 (lt) | 2018-01-13 |
AU2013248481B2 (en) | 2017-02-16 |
CA2869902C (en) | 2019-07-02 |
CA2869902A1 (en) | 2013-10-24 |
WO2013156329A1 (en) | 2013-10-24 |
HUE034902T2 (hu) | 2018-03-28 |
JP2015514731A (ja) | 2015-05-21 |
PL2838539T3 (pl) | 2018-01-31 |
RU2627846C2 (ru) | 2017-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT2838539T (lt) | Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymui | |
IL238180B (en) | Compounds of carbohydrates with glucose for the treatment of diabetic nephropathy and related disorders | |
GB2492487B (en) | Cannabinoids for use in the treatment of neurodegenerative diseases or disorders | |
SG10201912275YA (en) | Use of pyrazolopyrimidine derivatives for the treatment of pi3kd related disorders | |
PL3811943T3 (pl) | Związek do stosowania w leczeniu zaburzeń oczu | |
AP2014007804A0 (en) | Compositions and methods for the treatment of hepatic diseases and disorders. | |
HRP20190038T1 (hr) | Derivati pantotenata namijenjeni liječenju neuroloških poremećaja | |
IL235127A (en) | Hpn-100 for use in the treatment of nitrogen-related diseases | |
HK1192726A1 (en) | 1,2,4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseases 124--5- | |
ZA201306613B (en) | Combinations comprising macitentan for the treatment of glioblastoma multiforme | |
HK1219224A1 (zh) | 角結膜病症的治療劑 | |
ZA201408060B (en) | Compositions and methods for the treatment of neurological disorders | |
IL237912B (en) | History of dihydro-6-azaphenylene for the treatment of the central nervous system, oncological diseases and similar disorders | |
ZA201408061B (en) | Compositions and methods for the treatment of neurological disorders | |
EP2958570A4 (en) | THERAPEUTIC COMPOSITION FOR THE TREATMENT OF PERIANAL DISORDERS | |
AU2012900788A0 (en) | Combination treatment for rheumatic disorders |